Glutaredoxin 2 is essential for AML survival through mitochondrial permeability transition pore regulation.

Ling T, O'Brien C, St-Germain JR, Rondeau V, Shi M, Berman JM, Cepa A, Saez Raez P, Wunderlich M, Carter KM, Stillwell C, Sexton C, Culp-Hill R, Reisz JA, Adeel SA, Zeng AGX, Bansal S, Tsao E, Chen HT, Dick JE, Minden MD, Arruda A, Amaya ML, Tikhonova AN, Hope KJ, D'Alessandro A, Raught B, Jones CL

Open source

DOI: 10.1182/blood.2025028933
Published: 2026 Feb 19
Container: Blood
Publisher: Not recorded
Open access: yes

Credibility signals

limited evidence Score 45/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.

Show all credibility signals

cautionDOI registered: No matching Crossref record was present in this response. Source: Crossref; license: CC0 metadata
cautionDOI resolves: No matching Crossref record was present in this response. Source: Crossref; license: CC0 metadata
not scoredDirectory of Open Access Journals: No matching DOAJ record was present in this response. No allow-list match; this is not evidence of low credibility. Source: DOAJ; license: CC0
not scoredMEDLINE indexed: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredOpenAlex core source: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredKnown publisher allow-list: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredROR affiliation: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredRetraction Watch retraction: No retraction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredRetraction Watch expression of concern: No expression of concern notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredRetraction Watch correction: No correction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredRetraction Watch reinstatement: No reinstatement notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
supportingOpen access status: Normalized open-access status: open. Source: Normalized work metadata; license: Caller-provided; provenance license not supplied to scorer
not scoredPublication license: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredPublication version: A publication version was supplied but is not scored. Source: Normalized work metadata; license: Caller-provided; provenance license not supplied to scorer
cautionMetadata completeness: 5 of 6 scored descriptive metadata groups are present; missing fields increase uncertainty. Source: Normalized work metadata; license: Caller-provided; provenance license not supplied to scorer

Cite this work

BibTeX

@article{allodium:10.1182/blood.2025028933,
  title = {Glutaredoxin 2 is essential for AML survival through mitochondrial permeability transition pore regulation.},
  author = {Ling T and O'Brien C and St-Germain JR and Rondeau V and Shi M and Berman JM and Cepa A and Saez Raez P and Wunderlich M and Carter KM and Stillwell C and Sexton C and Culp-Hill R and Reisz JA and Adeel SA and Zeng AGX and Bansal S and Tsao E and Chen HT and Dick JE and Minden MD and Arruda A and Amaya ML and Tikhonova AN and Hope KJ and D'Alessandro A and Raught B and Jones CL},
  year = {2026},
  journal = {Blood},
  doi = {10.1182/blood.2025028933},
  url = {https://doi.org/10.1182/blood.2025028933}
}

RIS

TY  - JOUR
TI  - Glutaredoxin 2 is essential for AML survival through mitochondrial permeability transition pore regulation.
AU  - Ling T
AU  - O'Brien C
AU  - St-Germain JR
AU  - Rondeau V
AU  - Shi M
AU  - Berman JM
AU  - Cepa A
AU  - Saez Raez P
AU  - Wunderlich M
AU  - Carter KM
AU  - Stillwell C
AU  - Sexton C
AU  - Culp-Hill R
AU  - Reisz JA
AU  - Adeel SA
AU  - Zeng AGX
AU  - Bansal S
AU  - Tsao E
AU  - Chen HT
AU  - Dick JE
AU  - Minden MD
AU  - Arruda A
AU  - Amaya ML
AU  - Tikhonova AN
AU  - Hope KJ
AU  - D'Alessandro A
AU  - Raught B
AU  - Jones CL
PY  - 2026
JO  - Blood
DO  - 10.1182/blood.2025028933
UR  - https://doi.org/10.1182/blood.2025028933
ER  -

APA

T, L., C, O., JR, S., V, R., M, S., JM, B., A, C., P, S. R., M, W., KM, C., C, S., C, S., R, C., JA, R., SA, A., AGX, Z., S, B., E, T., HT, C., JE, D., MD, M., A, A., ML, A., AN, T., KJ, H., A, D., B, R., & CL, J. (2026). Glutaredoxin 2 is essential for AML survival through mitochondrial permeability transition pore regulation.. Blood. https://doi.org/10.1182/blood.2025028933

Source records

pubmed · retrieved 2026-09-25T22:25:22.144Z